Inflammatory Bowel Disease During Pregnancy: What the Latest Research Shows
Pregnant women with inflammatory bowel disease (IBD) face unique health challenges, according to a 2023 study published in the *Journal of Crohn’s and Colitis*. The research, conducted by a team at the University of California, San Francisco, followed 240 patients with conditions like Crohn’s disease and ulcerative colitis throughout their pregnancies. Findings highlight the importance of tailored medical care to minimize risks for both mother and child.
Key Risks and Management Strategies
IBD flare-ups during pregnancy are associated with higher rates of preterm birth and low birth weight, according to the study. However, maintaining remission through medication—such as aminosalicylates or biologics—significantly reduces these risks. “Women with IBD should work closely with gastroenterologists and obstetricians to adjust treatment plans,” said Dr. Sarah Lee, a co-author of the study.
Medication Safety During Pregnancy
The research emphasized that certain IBD medications are safer than others during pregnancy. For example, anti-TNF agents like infliximab are generally considered low risk in the second trimester, while corticosteroids are avoided due to potential fetal growth restrictions. The American College of Gastroenterology (ACG) guidelines, updated in 2022, align with these recommendations, stressing that uncontrolled inflammation poses greater risks than most medications.
Pregnancy Outcomes and Long-Term Impacts
Women who maintained disease remission throughout pregnancy had outcomes comparable to those without IBD, the study found. However, those experiencing flare-ups had a 30% higher chance of preterm delivery. Long-term follow-up data from the study also showed that infants born to mothers with well-managed IBD had no increased risk of developmental delays.
Why This Matters for Patients and Providers
The findings underscore the need for personalized care. “IBD is not a reason to avoid pregnancy, but it does require proactive management,” said Dr. Michael Chen, a gastroenterologist at Cleveland Clinic. This aligns with broader trends in maternal health, where chronic disease management is increasingly prioritized to improve outcomes.
What Patients Should Know
– Preconception planning: Consult specialists to optimize IBD control before pregnancy.
– Medication review: Avoid teratogenic drugs and focus on evidence-based treatments.
– Regular monitoring: Frequent check-ups can detect flare-ups early.
For more information, visit the American College of Gastroenterology or consult a board-certified gastroenterologist.
Related reading